Silvestri Saunders Comprehensive Review for the NCLEX-RN Examination 5th Edition Pharmacology Test Bank

Silvestri Saunders Comprehensive Review for the NCLEX-RN Examination 5th Edition Pharmacology Test Bank. This is a complete and an all-inclusive guide to Silvestri Saunders Comprehensive Review for the NCLEX-RN Examination 5th Edition Pharmacology Test Bank. The inurseiisicaringiforiaiclientiinilabor. iThe inurse ireviewsitheiphysician’siprescriptionsiandinotesithat itheiclientihasiaiprescriptionifoributorphanolitartrate i(Stadol). iTheinurseiunderstandsithatithis imedicationisiprescribedifor: 1. Painirelief 2. Increasingiuterine icontractions 3. Decreasing iuterine icontractions 4. Promotingifetalilungimaturity ANS: i 1 Rationale:iTheiclientiinilaborimayibe igiveniparenteralianalgesiaiduringitheifirstistageiofilabor, iupitoi2itoi3 ihoursibeforeithe ianticipatedidelivery. iButorphanolitartrate iisiaimedicationithatimayibeiprescribediforipain irelief. i“Increasingiuterine icontractions,” i“decreasingiuterine icontractions,” iandi“promotingifetalilung imaturity”iare inotiactionsiofithisimedication. Test-TakingiStrategy:iKnowledgeiofitheiactioniofibutorphanolitartrate iisirequireditoianswerithis iquestion. iRememberithatithisimedicationiisiusediforipainirelief. iReviewitheiactioniofithisimedication iifyou i ihadidifficultyiwithithisiquestioniandiareiunfamiliariwithithisimedication. PTS: 1 DIF: LeveliofiCognitiveiAbility:iUnderstanding REF: Lehne, iR. i(2010). iPharmacologyiforinursingicare i(7thied.). iSt. iLouis: iSaunders.OBJ: i ClientiNeeds:iPhysiologicaliIntegrity TOP: ContentiArea:iPharmacology MSC: iIntegratediProcess:iNursingiProcess—Planning 2. The ipostpartum inurse iis icaring ifor ia iclient iwith ian iepidural icatheter iin iplace ifor iopioid ianalgesic iadministration ifollowing icesarean ibirth. iIf ithe iclient idevelops irespiratory idepression iandirequiresnaloxone i i(Narcan)iasianiantidote, itheiclientimayicomplainiofiwhichiofitheifollowing? 1. Increase iiniheripainilevel 2. Decrease iiniheripainilevel 3. Increase iinitheiamountiofiitchingifromitheiopioidiusediinitheiepidural 4. Decrease iinitheiamountiofiitchingifromithe iopioidiusediinitheiepidural ANS: i 1 Rationale:iRememberithatiopioidsiareiusediforiepiduralianalgesia. iNaloxone iisianiopioidiantagonist, iwhichireversesithe ieffectsiofiopioids. iIfiitiisigiven, itheiclientimayicomplainiofianiincreaseiiniheripain ilevel. iTherefore i“decrease iiniheripainilevel,”i“increase iinitheiamountiofiitchingifromitheiopioidiusediin itheiepidural,” iandi“decrease iinitheiamountiofiitchingifromitheiopioidiusediinitheiepidural”iareiincorrect. Test-TakingiStrategy:iToianswerithisiquestioniaccurately, iyouimustiknowithatiopioidianalgesicsiare itheimedicationsiusediwithiepiduralianalgesiaitoirelieve ipain. iTherefore iifinaloxone iisiadministerediasian iantidote iforianiopioidianalgesic, itheiclient’sipainiwilliincrease. iReviewitheieffectsiofinaloxone iifithis iquestioniwasidifficult. PTS: 1 DIF: LeveliofiCognitiveiAbility:iUnderstanding REF: Lehne, iR. i(2010). iPharmacologyiforinursingicare i(7thied.). iSt. iLouis: iSaunders.OBJ: i ClientiNeeds:iPhysiologicaliIntegrity TOP: ContentiArea:iPharmacology MSC: iIntegratediProcess:iNursingiProcess—Assessment 3. Aiclientiexperiencingipretermilaboriatithe itwenty-ninthiweekiofigestationihasibeeniadmitteditoithe ihospital. iTheiclientihasiaiprescriptionitoireceiveibetamethasonei(Celestone). iTheinurse iunderstands ithatthe i imedicationiwillidoiwhichiofitheifollowing? 1. Preventispontaneousidelivery. 2. Stopitheiuterine icontractions. 3. Promote imaturationiofitheifetalilungs. 4. Accelerate ithe igrowthirateiofitheifetus. ANS: i 3 Rationale:iBetamethasone i(Celestone)iisiclassifiediasianianti-inflammatoryiandicorticosteroid. iIt iincreasesitheisurfactantileveliandilungimaturityiinitheifetus, iwhichireducesitheiincidence iofirespiratory idistressisyndrome. iDeliveryimustibeidelayediforiatileasti48ihoursiafteriadministrationiofibetamethasoneito iallowitimeiforitheilungsiofitheifetusitoimature. Test-TakingiStrategy:iOptionsithatiareicomparable iorialikeiare inotilikelyitoibeicorrect. iWithithisiinimind, ieliminate i“preventispontaneousidelivery”iandi“stopitheiuterine icontractions.” iNote itheistrategiciwords i“twenty-ninthiweekiofigestation.” iSpecific iknowledgeiaboutitheimedicationiandiknowledge iof itheproblems i iencounteredibyipremature iinfantsiwilliassistiiniansweringithisiquestion. iReviewithe iaction iofithisimedicationiifithisiquestioniwasidifficult. PTS: 1 DIF: LeveliofiCognitiveiAbility:iUnderstanding REF: McKinney, iE., iJames, iS., iMurray, iS., i&Ashwill, i iJ. i(2009). iMaternal-childinursingi(3rdied.). iSt.Louis: i iSaunders. OBJ: ClientiNeeds:iPhysiologicaliIntegrity TOP: ContentiArea:iPharmacology MSC: iIntegratediProcess:iNursingiProcess—Planning 4. Aiclientiwithipreeclampsiaiisireceivingimagnesiumisulfate. iTheinurse iassessesithe iclienticlosely iforiwhichisigniofimagnesiumitoxicity? 1. Proteinuria 2. Hyperactive ideepitendonireflexes 3. Respiratoryirateiofi10ibreaths/min 4. Serumimagnesiumileveliofi5imEq/L ANS: i 3 Rationale:iMagnesiumitoxicityiisiairiskiassociatediwithimagnesiumisulfate itherapy. iSignsiof imagnesiumitoxicityirelate itoicentralinervousisystemi(CNS)idepressioniandiincludeirespiratoryidepression, ilossiofideepitendonireflexes, iandisuddenidropiinifetaliheartirateiand/orimaternaliheartirate iandiblood ipressure. Magnesiumiisiexcretedithroughitheikidneys. iIfirenaliimpairmentiisipresent, imagnesiumitoxicityicandevelop i iveryiquickly. iTherapeutic iserumilevelsiofimagnesiumiarei4itoi7imEq/L.